Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma

被引:2
|
作者
Huang, Tingting [1 ]
Tian, Wei [1 ]
Zhou, Qingqing [1 ]
Li, Jiajun [1 ]
Jiang, Zhiyuan [1 ]
Chen, Jinsi [1 ]
Ge, Chao [1 ]
Tian, Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Rpn10; prognosis; NE-kappa B; clear cell renal cell carcinoma; HEPATOCELLULAR-CARCINOMA; PROTEASOME; CANCER; MIGRATION;
D O I
10.1093/abbs/gmab078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proliferation, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NE-kappa B) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (I kappa B alpha) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of I kappa B alpha in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NE-kappa B pathways and is a prognostic indicator for patients with ccRCC.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
  • [21] TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression
    Dai, Lan
    Gu, Liying
    Ding, Chuanwei
    Qiu, Lihua
    Di, Wen
    CANCER LETTERS, 2009, 283 (02) : 159 - 167
  • [22] Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma
    Chen, Xiaochuan
    Weng, Youliang
    Li, Ying
    Fu, Wankai
    Huang, Zongwei
    Pan, Yuhui
    Hong, Wenquan
    Lin, Wanzun
    Lin, Xiandong
    Qiu, Sufang
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [23] αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance
    Ho, Pei-Yin
    Chueh, Shih-Chieh
    Chiou, Shyh-Horng
    Wang, Shuo-Meng
    Lin, Wei-Chou
    Lee, I-Liang
    Yang, Hsin-Yi
    Peng, Hsiang-Chi
    Lai, Ming-Kuen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1367 - 1377
  • [24] KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation
    Li, Gang
    Xie, Zun-Ke
    Zhu, Dong-Sheng
    Guo, Tao
    Cai, Qi-Liang
    Wang, Yi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (09) : 16517 - 16525
  • [25] Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma
    Jiang, Zhiyuan
    Zhou, Qingqing
    Ge, Chao
    Yang, Jing
    Li, Hong
    Chen, Taoyang
    Xie, Haiyang
    Cui, Ying
    Shao, Miaomiao
    Li, Jinjun
    Tian, Hua
    CANCER LETTERS, 2019, 447 : 1 - 11
  • [26] Taking a SPOP at renal cell carcinoma - unraveling a novel pathway for Tumor progression in clear cell RCC
    Patel, Hiren V.
    Doppalapudi, Sai K.
    Singer, Eric A.
    EBIOMEDICINE, 2020, 56
  • [27] SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway
    Wang, Jue
    Bi, Wenhao
    Lv, Renguang
    Wang, Zekun
    Xin, Qian
    Li, Kailin
    Chen, Yuan
    Liu, Qiji
    Zhang, Xiang
    CANCER LETTERS, 2024, 601
  • [28] SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway
    Han, Bo'ang
    Sun, Zhen
    Yu, Tingting
    Wang, Yu
    Kuang, Lun
    Li, Tianyuan
    Cai, Jing
    Cao, Qing
    Xu, Yuan
    Gao, Binbin
    Cheng, Steven Y.
    Yue, Shen
    Liu, Chen
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [29] ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
    Jinming Xu
    Yan Wang
    Jiahao Jiang
    Cong Yin
    Bentao Shi
    Journal of Translational Medicine, 21
  • [30] ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
    Xu, Jinming
    Wang, Yan
    Jiang, Jiahao
    Yin, Cong
    Shi, Bentao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)